Contineum Therapeutics Inc (CTNM)
NASDAQ
News
Market Data
Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
The current CTNM market cap is 427.26M. The company's latest EPS is USD 0.8832 and P/E is 18.72.
| Quarter End | Mar 2024 |
|---|---|
| USD ($) | |
| Total Revenue | 0 |
| Operating Income | -9.93M |
| Net Income | -8.42M |
| Year End December 30 2023 | 2023 |
|---|---|
| USD ($) | |
| Total Revenue | 50M |
| Operating Income | 16.08M |
| Net Income | 22.72M |
| Quarter End | Mar 2024 |
|---|---|
| USD ($) | |
| Total Assets | 123.56M |
| Total Liabilities | 6.57M |
| Total Equity | -75.63M |
| Year End December 30 2023 | 2023 |
|---|---|
| USD ($) | |
| Total Assets | 130.39M |
| Total Liabilities | 5.7M |
| Total Equity | -67.94M |
| Market Cap | 427.26M |
| Price to Earnings Ratio | 18.72 |
| Price to Sales Ratio | 8.5 |
| Price to Cash Ratio | 27.39 |
| Price to Book Ratio | 3.41 |
| Dividend Yield | - |
| Shares Outstanding | 25.72M |
| Average Volume (1 week) | 50.35k |
| Average Volume (1 Month) | 64.23k |
| 52 Week Change | 14.55% |
| 52 Week High | 22.00 |
| 52 Week Low | 13.27 |
| Spread (Intraday) | 3.12 (18.22%) |
| Company Name | Contineum Therapeutics Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.contineum-tx.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
